Insulinoma

Insulinomas are the most common islet cell tumors and are located almost exclusively in the pancreas. Most of these tumors are sporadic, but they may also be associated with the multiple endocrine neoplasia type I syndrome. More than 90% of insulinomas are benign. Preoperative radiographic localizat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current treatment options in oncology 2003-08, Vol.4 (4), p.309-317
Hauptverfasser: Burns, Andrew R, Dackiw, Alan P B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 317
container_issue 4
container_start_page 309
container_title Current treatment options in oncology
container_volume 4
creator Burns, Andrew R
Dackiw, Alan P B
description Insulinomas are the most common islet cell tumors and are located almost exclusively in the pancreas. Most of these tumors are sporadic, but they may also be associated with the multiple endocrine neoplasia type I syndrome. More than 90% of insulinomas are benign. Preoperative radiographic localization may prove difficult. Intraoperative palpation and ultrasound remain the gold standard for detection and appropriately planned resection. Although many options are available to treat the patient with malignant and metastatic disease, the mainstay of treatment remains surgery. Laparoscopic ultrasound and enucleation/resection may be increasingly used in the management of patients with insulinoma.
doi_str_mv 10.1007/s11864-003-0006-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73526313</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2794398961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c268t-b75bf38c204e57a5ffc7a40514afb5147a44834e5946db1d9a7df33f40731bb73</originalsourceid><addsrcrecordid>eNp9kEtLAzEQgIMo9qE_wIsXwVs0k8ljc5RitVDwoueQ7CbQso-66R76783SBcGDh5nJkG-G5CPkDtgTMKafE0ChBGUMczBFTxdkDhIFVVzry_HMNeWamxlZpLRnjEvBzDWZATcCFcCcLDZtGupd2zXuhlxFV6dwO9Ul-Vq_fq7e6fbjbbN62dKSq-JIvZY-YlFyJoLUTsZYaieYBOGizzk3osB8Z4SqPFTG6SoiRsE0gvcal-TxvPfQd99DSEfb7FIZ6tq1oRuS1Si5QsAMPvwB993Qt_ltlisl8teNgv8oAMBCK1WYTMGZKvsupT5Ee-h3jetPFpgdZdqzTJtl2lGmPeWZ-2nz4JtQ_U5M9vAHmVJrhQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1113876689</pqid></control><display><type>article</type><title>Insulinoma</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Burns, Andrew R ; Dackiw, Alan P B</creator><creatorcontrib>Burns, Andrew R ; Dackiw, Alan P B</creatorcontrib><description>Insulinomas are the most common islet cell tumors and are located almost exclusively in the pancreas. Most of these tumors are sporadic, but they may also be associated with the multiple endocrine neoplasia type I syndrome. More than 90% of insulinomas are benign. Preoperative radiographic localization may prove difficult. Intraoperative palpation and ultrasound remain the gold standard for detection and appropriately planned resection. Although many options are available to treat the patient with malignant and metastatic disease, the mainstay of treatment remains surgery. Laparoscopic ultrasound and enucleation/resection may be increasingly used in the management of patients with insulinoma.</description><identifier>ISSN: 1527-2729</identifier><identifier>EISSN: 1534-6277</identifier><identifier>EISSN: 1534-5277</identifier><identifier>DOI: 10.1007/s11864-003-0006-y</identifier><identifier>PMID: 12943611</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Enucleation ; Humans ; Hypoglycemia ; Insulinoma ; Insulinoma - drug therapy ; Insulinoma - radiotherapy ; Insulinoma - surgery ; Insulinoma - therapy ; Localization ; Metastases ; Multiple endocrine neoplasia ; Neuroendocrine tumors ; Pancreatic cancer ; Patients ; Tumors ; Ultrasonic imaging ; Ultrasound</subject><ispartof>Current treatment options in oncology, 2003-08, Vol.4 (4), p.309-317</ispartof><rights>Current Science Inc. 2003</rights><rights>Current Science Inc 2003.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c268t-b75bf38c204e57a5ffc7a40514afb5147a44834e5946db1d9a7df33f40731bb73</citedby><cites>FETCH-LOGICAL-c268t-b75bf38c204e57a5ffc7a40514afb5147a44834e5946db1d9a7df33f40731bb73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12943611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burns, Andrew R</creatorcontrib><creatorcontrib>Dackiw, Alan P B</creatorcontrib><title>Insulinoma</title><title>Current treatment options in oncology</title><addtitle>Curr Treat Options Oncol</addtitle><description>Insulinomas are the most common islet cell tumors and are located almost exclusively in the pancreas. Most of these tumors are sporadic, but they may also be associated with the multiple endocrine neoplasia type I syndrome. More than 90% of insulinomas are benign. Preoperative radiographic localization may prove difficult. Intraoperative palpation and ultrasound remain the gold standard for detection and appropriately planned resection. Although many options are available to treat the patient with malignant and metastatic disease, the mainstay of treatment remains surgery. Laparoscopic ultrasound and enucleation/resection may be increasingly used in the management of patients with insulinoma.</description><subject>Enucleation</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Insulinoma</subject><subject>Insulinoma - drug therapy</subject><subject>Insulinoma - radiotherapy</subject><subject>Insulinoma - surgery</subject><subject>Insulinoma - therapy</subject><subject>Localization</subject><subject>Metastases</subject><subject>Multiple endocrine neoplasia</subject><subject>Neuroendocrine tumors</subject><subject>Pancreatic cancer</subject><subject>Patients</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><subject>Ultrasound</subject><issn>1527-2729</issn><issn>1534-6277</issn><issn>1534-5277</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kEtLAzEQgIMo9qE_wIsXwVs0k8ljc5RitVDwoueQ7CbQso-66R76783SBcGDh5nJkG-G5CPkDtgTMKafE0ChBGUMczBFTxdkDhIFVVzry_HMNeWamxlZpLRnjEvBzDWZATcCFcCcLDZtGupd2zXuhlxFV6dwO9Ul-Vq_fq7e6fbjbbN62dKSq-JIvZY-YlFyJoLUTsZYaieYBOGizzk3osB8Z4SqPFTG6SoiRsE0gvcal-TxvPfQd99DSEfb7FIZ6tq1oRuS1Si5QsAMPvwB993Qt_ltlisl8teNgv8oAMBCK1WYTMGZKvsupT5Ee-h3jetPFpgdZdqzTJtl2lGmPeWZ-2nz4JtQ_U5M9vAHmVJrhQ</recordid><startdate>20030801</startdate><enddate>20030801</enddate><creator>Burns, Andrew R</creator><creator>Dackiw, Alan P B</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20030801</creationdate><title>Insulinoma</title><author>Burns, Andrew R ; Dackiw, Alan P B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c268t-b75bf38c204e57a5ffc7a40514afb5147a44834e5946db1d9a7df33f40731bb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Enucleation</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Insulinoma</topic><topic>Insulinoma - drug therapy</topic><topic>Insulinoma - radiotherapy</topic><topic>Insulinoma - surgery</topic><topic>Insulinoma - therapy</topic><topic>Localization</topic><topic>Metastases</topic><topic>Multiple endocrine neoplasia</topic><topic>Neuroendocrine tumors</topic><topic>Pancreatic cancer</topic><topic>Patients</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burns, Andrew R</creatorcontrib><creatorcontrib>Dackiw, Alan P B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Current treatment options in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burns, Andrew R</au><au>Dackiw, Alan P B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insulinoma</atitle><jtitle>Current treatment options in oncology</jtitle><addtitle>Curr Treat Options Oncol</addtitle><date>2003-08-01</date><risdate>2003</risdate><volume>4</volume><issue>4</issue><spage>309</spage><epage>317</epage><pages>309-317</pages><issn>1527-2729</issn><eissn>1534-6277</eissn><eissn>1534-5277</eissn><abstract>Insulinomas are the most common islet cell tumors and are located almost exclusively in the pancreas. Most of these tumors are sporadic, but they may also be associated with the multiple endocrine neoplasia type I syndrome. More than 90% of insulinomas are benign. Preoperative radiographic localization may prove difficult. Intraoperative palpation and ultrasound remain the gold standard for detection and appropriately planned resection. Although many options are available to treat the patient with malignant and metastatic disease, the mainstay of treatment remains surgery. Laparoscopic ultrasound and enucleation/resection may be increasingly used in the management of patients with insulinoma.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>12943611</pmid><doi>10.1007/s11864-003-0006-y</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1527-2729
ispartof Current treatment options in oncology, 2003-08, Vol.4 (4), p.309-317
issn 1527-2729
1534-6277
1534-5277
language eng
recordid cdi_proquest_miscellaneous_73526313
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Enucleation
Humans
Hypoglycemia
Insulinoma
Insulinoma - drug therapy
Insulinoma - radiotherapy
Insulinoma - surgery
Insulinoma - therapy
Localization
Metastases
Multiple endocrine neoplasia
Neuroendocrine tumors
Pancreatic cancer
Patients
Tumors
Ultrasonic imaging
Ultrasound
title Insulinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T12%3A55%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insulinoma&rft.jtitle=Current%20treatment%20options%20in%20oncology&rft.au=Burns,%20Andrew%20R&rft.date=2003-08-01&rft.volume=4&rft.issue=4&rft.spage=309&rft.epage=317&rft.pages=309-317&rft.issn=1527-2729&rft.eissn=1534-6277&rft_id=info:doi/10.1007/s11864-003-0006-y&rft_dat=%3Cproquest_cross%3E2794398961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1113876689&rft_id=info:pmid/12943611&rfr_iscdi=true